COVID-19 is an infectious respiratory disease caused by the SARS-CoV-2 virus and is more serious in older people and those with certain health conditions. Since the introduction of the Delta variant in 2021, COVID boosters have been offered to those most at risk.
This winter was the second winter season where COVID boosters were offered, a time when the national COVID vaccination programme was winding down and circulation of respiratory viruses increased. This talk will explore the future of COVID boosters and will consider future drifts and shifts of the SARS-CoV-2, population immunity, reduction of severe disease and future technologies.
Dr Catherine Heffernan, Director of Health Improvement & SWL Public Health Consultant, SWL ICB & South London Partnership